Finanzas de Brightspring Health Services Inc (BTSG)BTSGBrightspring Health Services Inc

Brightspring Health Services Inc (BTSG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy Solutions, accounting for 88.0% of total sales, equivalent to $3.41B. Another important revenue stream is Provider Services. Understanding this composition is critical for investors evaluating how BTSG navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Brightspring Health Services Inc maintains a gross margin of 12.72%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.37%, while the net margin is 2.24%. These profitability ratios, combined with a Return on Equity (ROE) of 13.11%, provide a clear picture of how effectively BTSG converts its operational activities into shareholder value.

In the context of the broader market, BTSG competes directly with industry leaders such as DVA and EHC. With a market capitalization of $12.05B, it holds a significant position in the sector. When comparing efficiency, BTSG's gross margin of 12.72% stands against DVA's 27.98% and EHC's 90.20%. Such benchmarking helps identify whether Brightspring Health Services Inc is trading at a premium or discount relative to its financial performance.

Brightspring has demonstrated robust financial performance with a consistent increase in total revenue, reaching $3.87 billion in Q2 2026, and a significant net income of $84.29 million in the same quarter. The gross margin has improved to 12.72% in Q2 2026, indicating better profitability.